(Q85084463)

English

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula

scientific article published on 11 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

Josep-Maria Ribera

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jakob R. Passweg

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

David Valcarcel

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Anna Sureda

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Carme Canals

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Reyes Arranz

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Dolores Caballero

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Mats Brune

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Rodrigo Martino

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Joan Besalduch

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Rafael Duarte

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Angel León

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Maria Jesus Pascual

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ana García-Noblejas

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Lucia López Corral

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jordi Sierra

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Norbert Schmitz

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

11 October 2011

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

97

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

310-317

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of blood and marrow transplantation for Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the Committee on Hodgkin's Disease Staging Classification

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21993674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2011.045757

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993674%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85084463&oldid=1760200655"